Design Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 02/12/2026 | 6.53 M | $61.22 M | 0.00% | 11.46% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 5.37 M | $50.39 M | 60.81% | 9.43% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 2.50 M | $23.45 M | -31.60% | 4.39% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 2.23 M | $20.95 M | 30.37% | 3.92% |
| BLACKROCK, INC. | 02/12/2026 | 2.12 M | $19.86 M | 3.56% | 3.72% |
| VANGUARD GROUP INC | 01/29/2026 | 1.63 M | $15.30 M | 12.97% | 2.86% |
| VIVO CAPITAL, LLC | 02/13/2026 | 1.61 M | $15.13 M | 100.00% | 2.83% |
| ALMITAS CAPITAL LLC | 02/17/2026 | 1.53 M | $14.36 M | 0.00% | 2.69% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 1.46 M | $13.71 M | 207.21% | 2.57% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.18 M | $11.07 M | 9.62% | 2.07% |
| WOODLINE PARTNERS LP | 02/17/2026 | 944.04 K | $8.86 M | 54.08% | 1.66% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 784.61 K | $7.36 M | -23.79% | 1.38% |
| FMR LLC | 02/17/2026 | 771.27 K | $7.23 M | 4.11% | 1.35% |
| MORGAN STANLEY | 02/13/2026 | 702.31 K | $6.59 M | 299.06% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 679.59 K | $6.38 M | -2.30% | 1.19% |
| STATE STREET CORP | 02/13/2026 | 647.64 K | $6.07 M | 2.09% | 1.14% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 612.77 K | $5.74 M | -0.76% | 1.08% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 521.00 K | $4.89 M | -73.33% | 0.91% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 500.00 K | $4.69 M | 100.00% | 0.88% |
| CITADEL ADVISORS LLC | 02/17/2026 | 459.87 K | $4.31 M | -16.99% | 0.81% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 438.89 K | $4.12 M | 17.58% | 0.77% |
| INVESCO LTD. | 02/19/2026 | 305.76 K | $2.87 M | 1,995.81% | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 297.92 K | $2.80 M | 6.47% | 0.52% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 287.10 K | $2.69 M | 4.67% | 0.50% |
| NORTHERN TRUST CORP | 02/17/2026 | 286.57 K | $2.69 M | -3.36% | 0.50% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 270.65 K | $2.54 M | 3.52% | 0.48% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 236.86 K | $2.22 M | -4.47% | 0.42% |
| JANE STREET GROUP, LLC | 02/12/2026 | 226.51 K | $2.12 M | 92.23% | 0.40% |
| MARSHALL WACE, LLP | 02/13/2026 | 225.53 K | $2.12 M | 100.00% | 0.40% |
| 02/17/2026 | 207.90 K | $1.95 M | 100.00% | 0.37% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 194.61 K | $1.83 M | 100.00% | 0.34% |
| ALGERT GLOBAL LLC | 02/17/2026 | 187.77 K | $1.76 M | 100.00% | 0.33% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 180.87 K | $1.70 M | 162.80% | 0.32% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 158.38 K | $1.49 M | 100.00% | 0.28% |
| ACUTA CAPITAL PARTNERS, LLC | 02/17/2026 | 150.91 K | $1.42 M | 100.00% | 0.27% |
| NUVEEN, LLC | 02/12/2026 | 125.26 K | $1.17 M | -5.84% | 0.22% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 109.76 K | $1.03 M | 100.00% | 0.19% |
| DIADEMA PARTNERS LP | 02/17/2026 | 100.32 K | $941.00 K | 100.00% | 0.18% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 99.97 K | $937.69 K | 100.00% | 0.18% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 94.83 K | $889.49 K | 1,747.42% | 0.17% |
| BARCLAYS PLC | 02/13/2026 | 87.06 K | $816.62 K | -1.27% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 84.98 K | $797.07 K | -2.86% | 0.15% |
| EAM INVESTORS, LLC | 02/12/2026 | 78.95 K | $740.54 K | 100.00% | 0.14% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 78.50 K | $736.33 K | -58.29% | 0.14% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/17/2026 | 69.52 K | $652.06 K | 5.40% | 0.12% |
| PALUMBO WEALTH MANAGEMENT LLC | 01/21/2026 | 69.38 K | $650.76 K | 33.21% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 61.85 K | $580.17 K | 341.08% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 57.80 K | $542.15 K | 13.66% | 0.10% |
| CANADA PENSION PLAN INVESTMENT BOARD | 02/17/2026 | 54.60 K | $512.15 K | 100.00% | 0.10% |
| SEI INVESTMENTS CO | 02/13/2026 | 52.73 K | $494.61 K | 100.00% | 0.09% |
Design Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 194 institutional investors and hedge funds held shares of Design Therapeutics Inc. The most heavily invested institutionals were:
DIMENSIONAL FUND ADVISORS LP: 431,840
VANGUARD FIDUCIARY TRUST CO: 195,658
Invesco Ltd.: 141,920
Nuveen, LLC: 126,815
Lynx1 Capital Management LP: 119,516
JANE STREET GROUP, LLC: 103,902
66.93% of Design Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 47.51 M shares in the last 24 months. This purchase volume represents approximately $492.65 M in transactions.